Secondary analysis of a 2019-20 RCT in Israeli healthcare personnel: among 228 prior low responders to egg-based IIV4, RIV4 recipients were 3.6 and 8.3 times as likely as IIV4 recipients to stop being low responders against A(H1N1)pdm09 and A(H3N2).
Secondary analysisn = 228
Sumner et al. Improved Immune Response Against Influenza A Viruses With Receipt of a Recombinant Influenza Vaccine in Healthcare Personnel With Prior Low Antibody Response to Egg-Based Influenza Vaccines, Israel, 2019-2020